Society for Immunotherapy of Cancer (SITC)

Donate to The Steven A. Rosenberg Scholars Fund! This Award is one of SITC's most prestigious opportunities for emerging leaders in immunotherapy. Learn more: https://lnkd.in/gnAndjNC #immunotherapy #donate

One week until the #SITC Cell Therapy Administration: Increasing Access to #IO Global Webinar. This webinar will examine how cell #therapies are being utilized around the globe and in resource limited settings. Moderators: Ghassan Abou-Alfa, MD, MBA of Memorial Sloan Kettering Cancer Center. Faculty: Fidel David Huitzil Meléndez, MD of Centro Médico ABC, Ashraf Omar, MD, MSc of Cairo University & Dr. Bhawna Sirohi, MBBS, FRCP of BALCO Medical Centre (A Unit of Vedanta Médical Research Foundation). To register for this webinar, as well as the rest of the #Global Webinar Series, visit: go.sitcancer.org/4aLNYl3

Next week is the #SITC Targets for #Cancer #IO Webinar: #Tumor-targeted Delivery of #Immune Modulators on Tuesday, July 9 from 12–2 p.m. EDT. Moderators: Rafi Ahmed, PhD, FAIO of Winship Cancer Institute of Emory University & Pablo Umaña, PhD of Roche. Faculty: Laura Codarri Deak, PhD of Roche, Daniela Thommen, MD, PhD of The Netherlands Cancer Institute & Karl Dane Wittrup, PhD of MIT Koch Institute for Integrative Cancer Research. Current studies investigating the clinical potential of these #therapies, such as engineered #antibodies, STING agonists and #oncolytic viruses, will be addressed, as well as future outlooks for these therapies. To register for this webinar, as well as the remaining webinars, please visit: go.sitcancer.org/49J9NkW

#SITC24 Science Preview: Join Lawrence Fong, MD, Fred Hutchinson Cancer Center, Sergio Quezada, PhD, University College London, Aurélien Marabelle, MD, PhD, Gustave Roussy, Jan Joseph Melenhorst, PhD, Cleveland Clinic and Cathy Wu MD, Dana-Farber Cancer Institute.   This session will discuss the roles of CD4 T cells and regulatory T cells in anti-cancer immunity. Faculty presentations will address tumor antigen recognition by CD4 T cells, approaches to targeting regulatory T cells, and the role of CD4 CAR T cells in cancer immunotherapy.   View session details: https://lnkd.in/gAvQSENq

Register for the #AI in #IO Webinar on July 30! This webinar will focus on new, prospective methods to analyze #health record data for social determinant indicators that could help enhance #immunotherapy administration and access. To learn more, please visit: go.sitcancer.org/3PXMoEB Faculty: Danielle Bitterman, MD of Dana-Farber Cancer Institute & Moderator: Matthew Reilley, MD of University of Virginia/HealthSouth L.L.C.

TWO WEEKS LEFT to nominate an investigator in #immunotherapy for SITC’s Steven A. Rosenberg Scholars Award. The recipient will receive $150,000 in research funding and be recognized during an Award Ceremony at #SITC24. LEARN MORE: https://lnkd.in/emXABZ7n #SITCForwardFund

Implement the latest FDA-approved cancer immunotherapies into practice & improve patient outcomes with @sitcancer's Clinical Practice Guidelines. Guidelines feature recommended therapies, toxicity management & more! Learn more: https://lnkd.in/gpGDucyh #CIM24 #EndCancer

Nominate for the Steven A. Rosenberg Scholars Award! Support emerging leaders in immuno-oncology during #CIM24. Eligible: post-docs, residents, research scientists or within 5 years of their first academic appointment. Deadline: July 15, 2024! https://lnkd.in/gK74AaaV

The #SITC 2024 #Tumor Infiltrating #Lymphocytes (TIL) Symposium provides an in-depth discussion on the path to approval for #TIL therapy, current #clinical management, and the impact of recent #FDA approved therapies. This pre-conference program will consist of three sessions: - Session I: The Path to TIL Approval and Current Clinical Management - Session II: Next Generation TIL - Session III: Innovative Pre-Clinical TIL Development For more information and to register for the TIL Symposium, visit: sitcancer.org/2024 Organizers: Chantale Bernatchez, PhD of CTMC / A joint venture between Resilience + MD Anderson Cancer Center, Stephanie Goff, MD, FACS of the National Cancer Institute (NCI), and Shari Pilon-Thomas, PhD of Moffitt Cancer Center.

Excited to share the “Experiences by Women in Science and Medicine Listening Session” that I recently co-moderated with Dr Leisha Emens. The session aimed to highlight women’s professional and personal experiences in science and medicine, discuss challenges and obstacles women may encounter in advancing their careers, and identify strategies to support professional growth. So wonderful to sit down and chat (virtually) with these ladies. I hope you will enjoy hearing the diverse perspectives and Wonderful Words of Wisdom from these dynamic Women in cancer immunotherapy research as much as I did. 👩🏽🔬👩🏼🔬👩🏻🔬👩🔬 SITC is already doing great work to support the needs of women in science and medicine, but there is more to do. We can solve very complex problems collectively when diverse voices are included in the room. Grateful to be a part of an organization that acknowledges this, listens, and continues to think about new ways to move the needle going forward! #LeadingLadies #immunooncology